{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:43:27Z","timestamp":1782603807636,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI 110495"],"award-info":[{"award-number":["AI 110495"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10875-016-0331-0","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T02:38:44Z","timestamp":1474857524000},"page":"754-763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["\u201cHow I manage\u201d IgG4-Related Disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Emanuel","family":"Della-Torre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,26]]},"reference":[{"key":"331_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539\u201351.","journal-title":"N Engl J Med"},{"key":"331_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982\u201384.","journal-title":"J Gastroenterol"},{"key":"331_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181\u201392.","journal-title":"Mod Pathol"},{"key":"331_CR4","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385:1460\u201371.","journal-title":"Lancet"},{"key":"331_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/cei.12641","volume":"181","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol. 2015;181:191\u2013206.","journal-title":"Clin Exp Immunol"},{"key":"331_CR6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171\u20137.","journal-title":"Ann Rheum Dis"},{"key":"331_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1330","author":"H Mattoo","year":"2016","unstructured":"Mattoo H, Mahajan VS, Maehara T, Deshpande V, Della-Torre E, Wallace ZS, et al. Clonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016. doi:\n                    10.1016\/j.jaci.2015.12.1330\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"331_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/BOR.0b013e3283418057","volume":"23","author":"A Khosroshahi","year":"2011","unstructured":"Khosroshahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:57\u201366.","journal-title":"Curr Opin Rheumatol"},{"key":"331_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74:190\u20135.","journal-title":"Ann Rheum Dis"},{"key":"331_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","volume":"134","author":"H Mattoo","year":"2014","unstructured":"Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:679\u201387.","journal-title":"J Allergy Clin Immunol"},{"key":"331_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/art.33320","volume":"64","author":"A Tanaka","year":"2012","unstructured":"Tanaka A, Moriyama M, Nakashima H, Miyake K, Hayashida JN, Maehara T, et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum. 2012;64:254\u201363.","journal-title":"Arthritis Rheum"},{"key":"331_CR12","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/hep.21697","volume":"45","author":"Y Zen","year":"2007","unstructured":"Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, et al. Th2 and regulatory immune reactions are increased in immunoglobulin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45:1538\u201346.","journal-title":"Hepatology"},{"key":"331_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/all.12342","volume":"69","author":"H Mattoo","year":"2014","unstructured":"Mattoo H, Della-Torre E, Mahajan VS, Stone JH, Pillai S. Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy. Allergy. 2014;69:399\u2013402.","journal-title":"Allergy"},{"key":"331_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/all.12320","volume":"69","author":"E Della-Torre","year":"2014","unstructured":"Della-Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014;69:269\u201372.","journal-title":"Allergy"},{"key":"331_CR15","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1056\/NEJM200103083441005","volume":"344","author":"H Hamano","year":"2001","unstructured":"Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732\u20138.","journal-title":"N Engl J Med"},{"key":"331_CR16","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","volume":"55","author":"ZS Wallace","year":"2016","unstructured":"Wallace ZS, Mattoo H, Mahajan VS, Kulikova M, Lu L, Deshpande V, et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford). 2016;55:1000\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"331_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/BOR.0b013e328341a240","volume":"23","author":"A Khosroshahi","year":"2011","unstructured":"Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:67\u201371.","journal-title":"Curr Opin Rheumatol"},{"key":"331_CR18","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67:2466\u201375.","journal-title":"Arthritis Rheumatol"},{"key":"331_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","volume":"45","author":"C Campochiaro","year":"2016","unstructured":"Campochiaro C, Ramirez GA, Bozzolo EP, Lanzillotta M, Berti A, Baldissera E, et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45:135\u201345.","journal-title":"Scand J Rheumatol"},{"key":"331_CR20","doi-asserted-by":"publisher","first-page":"259408","DOI":"10.1155\/2012\/259408","volume":"2012","author":"MN Carruthers","year":"2012","unstructured":"Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD Responder Index. Int J Rheumatol. 2012;2012:259408.","journal-title":"Int J Rheumatol"},{"key":"331_CR21","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015;67:1688\u201399.","journal-title":"Arthritis Rheumatol"},{"key":"331_CR22","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/rheumatology\/kev244","volume":"54","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre E, Campochiaro C, Bozzolo EP, Dagna L, Scotti R, Nicoletti R, et al. Methotrexate for maintenance of remission in IgG4-related disease. Rheumatology (Oxford). 2015;54:1934\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"331_CR23","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.27435","volume":"62","author":"A Khosroshahi","year":"2010","unstructured":"Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755\u201362.","journal-title":"Arthritis Rheum"},{"key":"331_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","volume":"91","author":"A Khosroshahi","year":"2012","unstructured":"Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore). 2012;91:57\u201366.","journal-title":"Medicine (Baltimore)"},{"key":"331_CR25","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1136\/annrheumdis-2014-205799","volume":"74","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015;74:2236\u201343.","journal-title":"Ann Rheum Dis"},{"key":"331_CR26","doi-asserted-by":"crossref","unstructured":"Perugino CA, Wallace ZS, Meyersohn N, Oliveira G, Stone JR, Stone JH. Large vessel involvement by IgG4-related disease. Medicine 2016 (accepted).","DOI":"10.1097\/MD.0000000000003344"},{"issue":"3","key":"331_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/ki.2012.382","volume":"83","author":"MP Alexander","year":"2013","unstructured":"Alexander MP, Larsen CP, Gibson IW, Nasr SH, Sethi S, Fidler ME, et al. Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int. 2013;83(3):455\u201362.","journal-title":"Kidney Int"},{"key":"331_CR28","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/ki.2013.191","volume":"84","author":"T Saeki","year":"2013","unstructured":"Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Nakashima H, et al. The clinical course of patients with IgG4-related kidney disease. Kidney Int. 2013;84:826\u201333.","journal-title":"Kidney Int"},{"key":"331_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrgastro.2010.81","volume":"7","author":"T Kamisawa","year":"2010","unstructured":"Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol. 2010;7:401\u20139.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"331_CR30","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","volume":"134","author":"A Ghazale","year":"2008","unstructured":"Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4- associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706\u201315.","journal-title":"Gastroenterology"},{"key":"331_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/BOR.0b013e3283412f60","volume":"23","author":"K Takuma","year":"2011","unstructured":"Takuma K, Kamisawa T, Igarashi Y. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis. Curr Opin Rheumatol. 2011;23:80\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"331_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","volume":"40","author":"T Shimosegawa","year":"2011","unstructured":"Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352\u20138.","journal-title":"Pancreas"},{"key":"331_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11938-015-0057-8","volume":"13","author":"PA Hart","year":"2015","unstructured":"Hart PA, Conwell DL. Diagnosis of exocrine pancreatic insufficiency. Curr Treat Options Gastroenterol. 2015;13:347\u201353.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"331_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/jcp.2010.085613","volume":"64","author":"JD Strehl","year":"2011","unstructured":"Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011;64:237\u201343.","journal-title":"J Clin Pathol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-016-0331-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-016-0331-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-016-0331-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T09:47:40Z","timestamp":1589708860000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-016-0331-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,26]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1007\/s10875-016-0331-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,26]]},"assertion":[{"value":"24 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Stone reports receiving research grants and performing consulting for Roche and Xencor. Dr. Della Torre has performed consulting work for Roche.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}